Terms: = Lymphoma AND MLLT1, ENL, 4298, ENSG00000130382, Q03111, YEATS1, LTG19 AND Clinical Outcome
3 results:
1. Transcription control by the enl YEATS domain in acute leukaemia.
Erb MA; Scott TG; Li BE; Xie H; Paulk J; Seo HS; Souza A; Roberts JM; Dastjerdi S; Buckley DL; Sanjana NE; Shalem O; Nabet B; Zeid R; Offei-Addo NK; Dhe-Paganon S; Zhang F; Orkin SH; Winter GE; Bradner JE
Nature; 2017 Mar; 543(7644):270-274. PubMed ID: 28241139
[TBL] [Abstract] [Full Text] [Related]
2. clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/enl fusion gene.
Elia L; Grammatico S; Paoloni F; Vignetti M; Rago A; Cenfra N; Mecarocci S; Mancini M; Luciani M; Di Raimondo F; Cazzaniga G; Matarazzo M; Moleti ML; Santoro L; Gaidano G; Foà R; Mandelli F; Cimino G
Am J Hematol; 2011 Dec; 86(12):993-7. PubMed ID: 21953510
[TBL] [Abstract] [Full Text] [Related]
3. A multiplex reverse transcriptase-polymerase chain reaction strategy for the diagnostic molecular screening of chimeric genes: a clinical evaluation on 170 patients with acute lymphoblastic leukemia.
Elia L; Mancini M; Moleti L; Meloni G; Buffolino S; Krampera M; De Rossi G; Foà R; Cimino G
Haematologica; 2003 Mar; 88(3):275-9. PubMed ID: 12651265
[TBL] [Abstract] [Full Text] [Related]
